AXGN
AxoGen, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$48.28
+2.51%Leverage
- Debt / equity
- 0.08x
- Net debt / equity
- -0.29x
- Debt / assets
- 0.07x
- Debt / EBITDA
- -1.36x
- Net debt / EBITDA
- 5.04x
Liquidity & coverage
- Current ratio
- 6.60x
- Quick ratio
- 5.04x
- Cash ratio
- 3.11x
- Interest coverage
- -1.02x
- EBITDA / interest
- -1.17x
- Working capital
- $170.0M
Cash & dividend
- FCF / debt
- 0.13x
- Cash flow / debt
- 0.46x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- +1566.7%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026